Rheumatoid Factor Human Plasma

<strong>Rheumatoid Factor Human Plasma_x000D_ </strong>_x000D_ <table width="643">_x000D_ <tbody>_x000D_ <tr>_x000D_ <td>Catalog number:</td>_x000D_ <td>S2010001B</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Lot number:</td>_x000D_ <td>Batch dependent</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Expiration date:</td>_x000D_ <td>Batch depdendent</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Concentration:</td>_x000D_ <td><span class="ILfuVd NA6bn"><span class="hgKElc">≥ </span></span>1000 IU/mL</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Package Size:</td>_x000D_ <td>Bulk (1 mL to 10 L)</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Appearance:</td>_x000D_ <td>Slightly turbid</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Species:</td>_x000D_ <td>Human</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Matrix:</td>_x000D_ <td>Human plasma</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Storage:</td>_x000D_ <td>-20°C. Avoid repeated freeze-thaw.</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Other names:</td>_x000D_ <td>RF, rheumatoid arthritis factor, rheumatoid arthritis antibody</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Keywords:</td>_x000D_ <td>Rheumatoid Factor, RF, rheumatoid arthritis factor, rheumatoid arthritis antibody, RF positive plasma, RF positive control, Rheumatoid Factor Positive Control</td>_x000D_ </tr>_x000D_ </tbody>_x000D_ </table>_x000D_ <strong>References_x000D_ </strong>_x000D_ <ul>_x000D_ <li>Hollander, J. L. (1968). Rheumatoid Arthritis, Rheumatoid Factor, and Gamma G Globulin Fragments. <em>Annals of Internal Medicine</em>, <em>68</em>(5), 1195.</li>_x000D_ <li>Pappas, D. A., and Bathon, J. M. (2009). Treatment of Rheumatoid Arthritis: Tumor Necrosis Factor Inhibitors. <em>Rheumatoid Arthritis</em>, 337–349.</li>_x000D_ <li>Shingu, M., Ezaki, I., and Nobunaga, M. (1988). Complement-activating properties of immune complexes are suppressed by IgM rheumatoid factor and enhanced by IgG rheumatoid factor. <em>Rheumatology International</em>, <em>8</em>(3), 95–100.</li>_x000D_ <li>Vaughan, J. H. (1993). Pathogenetic concepts and origins of rheumatoid factor in rheumatoid arthritis. <em>Arthritis and Rheumatism</em>, <em>36</em>(1), 1–6.</li>_x000D_ <li>Xing Q, Fu L, Yu Z, Zhou X. Efficacy and Safety of Integrated Traditional Chinese Medicine and Western Medicine on the Treatment of Rheumatoid Arthritis: A Meta-Analysis<a href="https://www.ncbi.nlm.nih.gov/pubmed/32328130">.</a> <span class="jrnl" title="Evidence-based complementary and alternative medicine : eCAM">Evid Based Complement Alternat Med</span>. 2020 Apr 2;2020:4348709.</li>_x000D_ <li>Raine C, Austin K, Giles I. Mechanisms determining the amelioration of rheumatoid arthritis in pregnancy: A systematic review. <span class="jrnl" title="Seminars in arthritis and rheumatism">Semin Arthritis Rheum</span>. 2020 Mar 19. pii: S0049-0172(20)30079-2.</li>_x000D_ <li>Toussirot E. The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition. <a href="https://www.ncbi.nlm.nih.gov/pubmed/32183053"><span class="jrnl" title="Metabolites">Metabolites</span></a>. 2020 Mar 13;10(3). pii: E107.</li>_x000D_ <li>Ishikawa Y, Terao C. The Impact of Cigarette Smoking on Risk of Rheumatoid Arthritis: A Narrative Review. <span class="jrnl" title="Cells">Cells</span>. 2020 Feb 19;9(2). pii: E475.</li>_x000D_ <li>Lin YJ, Anzaghe M, Schülke S. Update on the Pathomechanism, Diagnosis, and Treatment Options for <b>Rheumatoid</b> Arthritis. <span class="jrnl" title="Cells">Cells</span>. 2020 Apr 3;9(4). pii: E880.</li>_x000D_ <li>Capone A, Volpe E. Transcriptional Regulators of T Helper 17 Cell Differentiation in Health and Autoimmune Diseases. <span class="jrnl" title="Frontiers in immunology">Front Immunol</span>. 2020 Mar 12;11:348.</li>_x000D_ </ul>_x000D_ &nbsp;_x000D_ _x000D_ <strong>Related Products to Rheumatoid Factor Human Plasma: <a href="https://moleculardepot.com/?s=Rheumatoid+factor&amp;post_type=product">RF</a>_x000D_ </strong>_x000D_ _x000D_ &nbsp;